BBI Cambridge is the UK operating company of the Biotechnology Business Institute based in Barcelona.
No data available
Findacure is a UK charity that is building the rare disease community to drive research and develop treatments. We work to: 1) Empower patient groups to build their patient community, develop as a charity and drive research; 2) Promote collaboration between rare disease stakeholders to facilitate treatment development for all.
Watch our member showcase video here https://bit.ly/3rhRi2D
Watch our member showcase video here https://bit.ly/3rhRi2D
Main activities are: fundraising for early stage life science companies, helping companies become investment ready; advice on obtaining R&D grants; interim and financial management for early stage companies; and contributing to board decisions as non-executive director. Experience includes raising equity for eight life science companies and obtaining R&D grants for 16 others. Also 12 years managing small companies and a number of non-executive director posts.
Bicycle has developed a proprietary bicyclic peptide technology that enables the discovery of a new class of drug candidates with antibody-like selectivity and specificity. The company is well financed by a group of top-tier VCs and is applying the technology to drug discovery projects in several therapeutic areas. The company also plans to also enter selected research collaborations to make the platform available to pharma partners.
Bidwells is the leading property consultancy in the Oxford-Cambridge Arc, advising on over half of all science and technology space in the region. We manage over £5.2bn in property assets for national and international investors, and serve as a gateway to highly attractive markets for science and technology corporations and investors. We help businesses to find or develop new office and laboratory space, project manage fit-outs and refurbishments, and we provide building and planning consultancy, relocation and acquisition advice, and lease consultancy.
BioAgilytix is the trusted partner for bioanalytical services throughout every phase of the drug development process. As a leading global bioanalytical laboratory, the company provides established and emerging pharmaceutical and biotechnology organizations with pharmacokinetic (PK), immunogenicity, biomarker, and CMC bioanalytical testing services in a GxP environment. BioAgilytix maintains state-of-the-art laboratories in Durham, North Carolina; Boston, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia; and Hamburg, Germany.
Biocair is a global GDP logistics specialist with over 35 years of experience in the pharmaceutical, biotechnology and life sciences sectors.
The company has built up a unique, client-centric approach by employing scientists in front-line logistics positions and assembling a team of best-in-class industry experts in quality, cold chain and regulatory compliance. Biocair focuses on providing the most comprehensive time-sensitive and temperature-controlled logistics services available whilst delivering flexible, tailored, cost-effective solutions to all clients.
The Biocair network operates 24/7 in over 160 countries across Europe, Africa, Asia and the Americas.
Watch our member showcase video here https://bit.ly/3K5dxBO
The company has built up a unique, client-centric approach by employing scientists in front-line logistics positions and assembling a team of best-in-class industry experts in quality, cold chain and regulatory compliance. Biocair focuses on providing the most comprehensive time-sensitive and temperature-controlled logistics services available whilst delivering flexible, tailored, cost-effective solutions to all clients.
The Biocair network operates 24/7 in over 160 countries across Europe, Africa, Asia and the Americas.
Watch our member showcase video here https://bit.ly/3K5dxBO
BioDuro is a US company founded in 1996, and headquartered in Irvine, California. With more than 2,000+ scientists, we have 7 R&D and manufacturing campuses across the US and China. We offer fully integrated CRDMO services from discovery to commercial manufacturing across medicinal chemistry, biology, DMPK, drug substance and drug product, including multiple modalities small molecules, peptides, oligonucleotides and antibody drug conjugates.
We leverage our broad capabilities and unique technology platforms to empower biotech and pharmaceutical partners worldwide. Our integrated approaches accelerate and de-risk new drug discovery and development, creating higher value outcomes for our clients. Committed to the highest standards of compliance and business operations, we maintain a science-driven, customer-oriented, innovative and people-focused culture.
As a pure-play CRDMO, BioDuro operates under one global standard, providing integrated, fast, and flexible services to meet the unique needs of our clients and accelerate development timelines.
We leverage our broad capabilities and unique technology platforms to empower biotech and pharmaceutical partners worldwide. Our integrated approaches accelerate and de-risk new drug discovery and development, creating higher value outcomes for our clients. Committed to the highest standards of compliance and business operations, we maintain a science-driven, customer-oriented, innovative and people-focused culture.
As a pure-play CRDMO, BioDuro operates under one global standard, providing integrated, fast, and flexible services to meet the unique needs of our clients and accelerate development timelines.
Biofidelity’s mission is to improve and extend cancer patients’ lives by enabling better targeting of therapies, early detection of treatment resistance, and routine monitoring of treatment response. Our unique technology is designed to allow rapid, broad adoption of our assays in testing labs around the world, enabling a step change in patient care.